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Abstract: The search for anticancer MMP-9 inhibitors (MMPIs) in food products has become a major
goal for research. MMPIs in soy have been related only to saponins and isoflavones, but recently, low
specific protein fractions in soybeans were shown to reduce MMP-9 activity as well. The present
work aimed at comparing the MMPI potential of protein fractions (P) and non-protein fractions (NP)
isolated from soybean seeds, before and after soaking and cooking, mimicking dietary exposures.
Reverse and substrate zymography, as well as a fluoregenic DQ gelatin assay were used to evaluate
MMP-9 activities. Colon cancer cell migration and proliferation was also tested in HT29 cells.
Regarding MMP-9 inhibition, proteins in soy presented IC50 values 100 times lower than non-protein
extracts, and remained active after cooking, suggesting that proteins may be more effective MMP-9
inhibitors than non-protein compounds. Using the determined IC50 concentrations, NP fractions
were able to induce higher inhibitions of HT29 cell migration and proliferation, but not through
MMP-9 inhibition, whilst protein fractions were shown to specifically inhibit MMP-9 activity. Overall,
our results show that protein fractions in soybeans might have a higher role in soy-related cancer
prevention as MMPIs than previously expected. Being nontoxic and active at lower concentrations,
the discovery of these heat-resistant specific MMPI proteins in soy can be of significant importance for
cancer preventive diets, particularly considering the increasing use of soy proteins in food products
and the controversy around isoflavones amongst consumers.
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1. Introduction
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases which are
involved in the remodeling of connective tissue [1]. One subgroup of MMPs called gelatinases
(MMP-2 and MMP-9) has been particularly recognized as important mediators in inflammation [2]
and oncologic processes such as tumorigenesis, cell adhesion and metastasis [3–7]. MMP-9 enzymes in
particular are highly expressed in colorectal cancer (CRC) and pre-cancer pathologies such as ulcerative
colitis and other inflammatory bowel diseases (IBDs) [8,9]. Therefore, it is no surprise that in the last
decade the search and development of MMP inhibitors (MMPIs), particularly MMP-9 inhibitors, has
become an important branch of research, both in academic as well as in industrial settings. Up to now,
numerous MMPIs have been tested in different clinical trials [10] and were already demonstrated to be
effective in reducing cancer progression/metastasis and also IBD symptoms [3,8,9,11–14]. However,
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targeting MMPs has proven itself difficult due to the fact that MMPs are ubiquitously indispensable
for normal development and physiology, and consequently their inhibition induces overall severe
adverse side effects [11,15]. In the case of colon cancer or inflammatory bowel diseases, a more
convenient and effective approach could be achieved, at least partly, through the long-term ingestion
of natural food-born specific MMP-9 inhibitors that may be colon-available. Such can be the case of
some legume seeds [16–18], among which soy (Glycine max L.) has inarguably become the best known
for its health-related benefits. Increasingly popular soy has been reported to have bioactivities against
cancer [19–21] osteoporosis [22,23] and coronary heart disease [24], among others.
As in other legumes, soybean’s anticancer activities are related to phenolic compounds, saponins
and phytic acid [25–28] as well as enzyme inhibitors such as the trypsin and the Bowman–Birk
inhibitors [29]. However, the most notable and exclusive anticancer compounds of soy are isoflavones
(a class of estrogen-like compounds generally known as phytoestrogens). The peptide lunasin, a small
subunit derived from the larger cotyledon-specific 2S seed albumin, also has both anticancer and
anti-inflammatory activities [30]. Thus far, soy isoflavones and saponins are the only two bioactive
compounds in soy that were shown to be effective MMP inhibitors [31], whilst BBIs were shown to
be more likely involved in suppressing the production of superoxide anion free radicals, targeting
cancer cells, or suppressing their growth [25,29,32–35]. Lunasin, according to Kyle et al. [36], does not
have a role in MMP inhibition as well, but rather, it involves physical interactions with chromatin
and histones [37]. Recently, Lima et al. [18] showed that the protein fraction of few legume seeds,
including soybeans can also inhibit MMP-9 in colon cancer cells. This was the first report showing
that soy proteins could inhibit MMPs. However, it is still not understood if these proteins have
higher MMPI activities than isoflavones or other non-protein compounds. This can be of particular
importance for the use of soy in anticancer preventive diets, since legume storage proteins are usually
non-toxic and have no anti-nutritional effect, and also because the amount of soyfoods and soy protein
additives that are used in the food industry are usually richer in the protein fraction rather than the
non-protein fraction.
Under this context, in the present work, we aimed to compare the MMPI activities in the protein
and non-protein fractions (polyphenols and saponins) of cooked and uncooked soybeans and to
determine which is the most effective to be used in healthier preventive diets. Our main objectives
were: (a) to quantify and characterize the presence of these compounds in soy seeds before and
after soaking and cooking; (b) to evaluate their effect on MMP-9 activity; (c) to test the effect of
these compounds in colon cancer cell migration and proliferation; and (d) to compare protein and
non-protein compounds for their potential in preventive diets.
2. Materials and Methods
2.1. Biological Materials
The biological materials used for the present study were the quiescent seeds of soybean
(Glycine max L.). The human colon adenocarcinoma cell line, HT29 (ECACC 85061109), obtained
from a 44-year-old Caucasian female, was also used throughout this work. HT29 cell lines were
maintained in RPMI medium supplemented with 10% (w/v) of heat-inactivated fetal bovine serum
(FBS) and 200 mM glutamine, 2 × 104 UI/mL penicillin and 20 mg/mL streptomycin at 37 ◦C, in a
humidified atmosphere of 5% (v/v) CO2.
2.2. Soy Seed Soaking and Heat Treatment
In this work, soy seeds were used dry and cooked, in order to mimic dietary exposures. For dry
weight determinations, soy seeds were dried at 50 ◦C until weight stabilization. For the cooking
treatments, seeds were soaked for 24 h at room temperature with deionized water (Mili-Q, Millipore
Corporation, Bedford, MA, USA) at a ratio of 1:3 (w/v). Legume seeds were then cooked in deionized
water in a ratio of 1:20 (w/v) in a metal container on a hot plate until they reached a soft texture [38].
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In both cooked and uncooked seeds, the protein and non-protein fractions were extracted for the
subsequent analysis.
2.3. Extraction and Quantification of Soluble Proteins
Legume seeds (uncooked and cooked) were ground in a Bimby® TM 31 cooking robot until
a fine and homogeneous powder was obtained. For protein extractions samples were mixed with
polyvinylpolypyrrolidone (PVPP) in a portion of 1:4 (w/w), and extracted with 100 mM Tris HCl buffer
at pH 7.5, in a ratio of 1:5 (w/v) as described earlier [19]. This solution was kept stirring overnight at
4 ◦C. Samples were then centrifuged in a Beckman J2-21M/E centrifuge at 12,000× g for 1 h at 4 ◦C, and
the supernatant was collected and then stored at −20 ◦C for further analysis. Protein quantification
was performed according to Bradford [39].
2.4. Extraction and Quantification of Non-Protein Compounds
Non-protein compounds were extracted according to the method described by Makkar and
Becker [40]. Samples were ground in a Bimby TM 31 cooking robot, as described in 2.3 and 80% (v/v)
methanol was added in a 1:20 (w/v) portion, and stirred overnight. The contents were centrifuged at
3500× g in a Beckman Coulter™ Allegra™ 25R centrifuge for 10 min and the supernatant collected.
The precipitate was washed three times with 80% (v/v) methanol in a portion of 1:10 (w/v), centrifuged
at 3500× g in a Beckman Coulter™ Allegra™ 25R centrifuge for 10 min, and the supernatant was
collected. The supernatant was then evaporated at 50 ◦C until dry.
2.4.1. Saponin Quantification
Total saponin content was quantified by the method described by Hiai et al. [41] using soybean
saponins as standard. To the extracts, a solution with 8% (v/v) of 1:5 (v/v) was added in a ratio of 1:4
(v/v), followed by a solution with 80% (v/v) of vanillin in ethanol and finally 1:50 (v/v) of 72% (w/v)
sulfuric acid. The mixture was allowed to stir in a water bath at 0 ◦C. Subsequently, the mixture was
heated in a bath with water at 60 ◦C for 10 min, and placed again in cold water until cool. Absorbance
was read at 544 nm on a Syenery HT spectrophotometer, Bio-TEK.
2.4.2. Polyphenolic Compounds
Polyphenolic compounds were quantified by the Folin–Ciocalteau reagent using gallic acid
as standard. The lyophilized powder was treated with 10 µL of 70% (v/v) acetone, 10 µL of 0.5%
(v/v) acetic acid and 80 µL of 7% (w/v) sodium carbonate. Subsequently, a volume of 100 µL of
Folin–Ciocalteau was added and the mixture was vortexed. The solution (200 µL) was incubated for
8 min at room temperature and the absorbance was read in a Syenery HT Bio-TEK spectrophotometer
at 765 nm [42].
2.5. Half Maximal Effective Inhibition of MMPs (IC50)
MMP-9 IC50 values were assessed in sterile 96-well plates (Greiner Bio-one, Germany), using
the micro dilution method as described before [43]. Briefly, 50 µL of RPMI medium was added to
each well. Then, concentrated samples (protein or non-protein extracts) were added to the first well
and serially diluted 1:2 to each adjacent well, up to 10 dilutions. Subsequently, 50 µL of the HT29
cell suspension with a concentration of 2 × 105 cells/mL was added to each wells. A positive control
(50 µL RPMI medium + 50 µL cell suspension) and a negative control (100 µL RPMI medium) were
performed. After 48 h growth, MMP-inhibition was tested using the DQ gelatin assay as described in
Lima et al. [18]. The fluorogenic dye-quenched (DQ)-gelatin substrate was purchased from Invitrogen
(Carlsbad, CA, USA) and dissolved in water at 1 mg/mL. All solutions and dilutions were prepared
in assay-buffer (50 mM Tris-HCl buffer, pH 7.6, containing 150 mM NaCl, 5 mM CaCl2 and 0.01%
v/v Tween 20). A 96-well micro-assay plate (chimney, 96-well, black) was used and each well was
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loaded with 100 µL of extracellular HT29 media (containing MMP-9 and MMP-2) after exposure to
the different concentrations of the soy extracts. Subsequently, DQ-gelatin (at a final concentration
of 2.5 µg/mL) was added to each well (for a final volume of 200 µL) and the plate was allowed to
incubate again, for 1 h. In the presence of active gelatinolytic activity the DQ-gelatin substrate becomes
fluorescent. Fluorescence levels were measured (excitation 485 nm/emission 530 nm). After plotting,
the value correspondent to a 50% gelatinase inhibition was selected as the IC50 for each fraction.
2.6. Specific MMP-9 Inhibition
In order to evaluate specific MMP-9 inhibition, the DQ gelatin assay was used once more, as
described in 2.5, but with some adaptations. Each well was loaded with 0.1 mM (for a final volume of
200 µL) MMP-9 (Sigma). Protein or non-protein extracts were added to the MMP-9 solution, in their
respective calculated EC50 concentrations (for a final volume of 200 µL), and the plate was incubated
for 1 h at 37 ◦C to allow inhibition. Subsequently, in order to quantify MMP-9 activity, DQ-gelatin (at a
final concentration of 2.5 µg/mL) was added to each well and the plate was allowed to incubate again,
for 1 h. Fluorescence levels were measured (excitation 485 nm/emission 530 nm). In each experiment,
both positive (no protein fraction) and negative (no enzyme) controls were included for all samples,
to correct for possible proteolytic activities present in the soy extracts. All data were corrected by
subtraction of their corresponding negative controls.
2.7. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
Cooked and uncooked soy samples were treated with 100 mM Tris-HCl buffer, pH 6.8, containing
100 mM β-mercaptoethanol, 2% (w/v) SDS, 15% (v/v) glycerol and 0.006% (w/v) m-cresol purple, and
heated at 100 ◦C for 5 min. One-dimension electrophoresis was carried out, following the method
described by Laemmly et al. [44] in a 12.5% (w/v) acrylamide resolving gel and a 5% (w/v) acrylamide
stacking gel, and performed in a vertical electrophoresis unit at 100 V and 20 mA per gel. Gels
were fixed for 20 min in 10% (w/v) TCA, and stained in 0.25% (w/v) Coomassie Brilliant Blue R-250,
25% (v/v) 2-propanol and 10% (v/v) acetic acid. Destaining was carried in a solution of 25% (v/v)
2-propanol and 10% (v/v) acetic acid.
2.8. Reverse Gelatin Zymography
Reverse zymography was used to detect and quantify MMPI proteins in the protein fractions
of cooked and uncooked seeds as described in Hawkes et al. [45], with some modifications. Protein
samples were treated with zymographic buffer (313 mM Tris-HCl buffer, pH 6.8, containing 10% (w/v)
SDS, 50% (v/v) glycerol and 0.05% (w/v) bromophenol blue) and loaded in SDS-polyacrylamide (12.5%
w/v acrylamide) gels copolymerized with gelatin (1% w/v) and 1 µmol/mL MMP-9. Electrophoresis
was performed as described in 2.5 and the gels were washed three times in 2.5% v/v Triton X-100,
for 60 min each, to remove SDS. Gels were then incubated overnight at 37 ◦C, with developing buffer
(50 mM Tris-HCl buffer, pH 7.4, containing 5 mM CaCl2, 1 µM ZnCl2 and 0.01% w/v sodium azide),
stained with Coomassie Brilliant Blue G-250 0.5% (w/v) in 50% (v/v) methanol and 10% (v/v) acetic
acid for 30 min, and destained with a solution of 50% (v/v) methanol, 10% (v/v) acetic acid in water.
Dark bands visible against a white background marked the MMPI-mediated inhibition of gelatin
degradation [45].
2.9. In Vitro Colon Cancer Cell Assays
2.9.1. Cell Migration Assay
For cell migration analysis, the wound healing assay was performed. HT29 cells (5 × 105 cells/
well) were seeded in 6-well plates and allowed to reach to 80% confluence. Wounds were performed
by making a scratch across the cell monolayer to create an open gap, mimicking a wound. Cells were
then washed twice with PBS to remove floating debris. Each well was subsequently filled with fresh
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media containing the samples under study, in a concentration of 100 µg/mL and allowed to grow for
48 h. The invaded area after 48 h was calculated in each treatment and compared to the initial area
at 0 h, to determine the area covered by migrating cells into the denuded zone at the beginning of
treatment. This comparison allowed us to assess the inhibitory effect (if any) exerted by each fraction,
on the HT29 cell migrating capacity.
2.9.2. Cell Proliferation Assay
HT29 cultured cells were seeded on 96-well plates (2 × 104 cells/well) and soy extracts were
added to the growth media in different concentrations, and incubated for 24 h. After each treatment,
the extracellular media was collected, and the wells were washed with PBS to remove unattached
cells. Cell proliferation and viability was determined using the standard 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described by Carmichael et al. [46].
2.10. Substrate Gelatin Zymography
To determine metalloproteinase activities in HT29 cancer cell culture supernatants, a
gelatin-zymography was performed according to standard methods [47], as described before but
SDS-polyacrylamide gels (12.5% w/v acrylamide) were copolymerized with 1% (w/v) gelatin. The cell
culture supernatants were treated with a non-reducing buffer (62.6 mM Tris-HCl buffer, pH 6.8,
containing 2% w/v SDS, 10% v/v glycerol and 0.01% w/v bromophenol blue) and loaded into each
well. After electrophoresis, gels were washed three times in 2.5% (v/v) Triton X-100 for 90 min each to
remove the SDS, incubated overnight with developing buffer and stained with Coomassie Brilliant
Blue G-250 as described above for reverse zymography. White bands visible against a blue background
marked the gelatinase activity of each proteinase [47].
2.11. Statistical Analysis
All experiments were performed in triplicate at least three independent times, and the data are
expressed as the mean ± standard deviation (SD). SigmaPlot software (version 12.5) was used for
comparing different treatments, using one-way and two-way analysis of variance (ANOVA). Tukey’s
test was used to compare differences between groups and the statistical differences with p value less
than 0.05 where considered statistically significant.
3. Results and Discussion
Currently, soybeans and soy-foods have become extremely popular in the food industry as a health
staple [48], with numerous observational and clinical studies supporting their claims [49,50]. Although
isoflavones and saponins are highly effective bioactive compounds, they can induce secondary
effects [51,52] that cause a lot of controversy in consumers. The recent discovery of a protein fraction
in soy with anticancer potential [18] may alter this view of soy-foods. In this work, we compared the
MMP inhibitory activities in the protein and non-protein fractions from soy.
Surprisingly, most studies testing anticancer activities in legumes use either uncooked seeds,
or the isolated bioactive compounds, such as the isoflavone genistein [18,31]. However, in order to
improve the nutritional quality of soy-foods, inhibitors such as lectins are generally inactivated by
soaking and heat treatment during food processing. Since cooking and soaking is known to reduce
or destroy the nutritional compounds in foods, in a more realistic perspective, the consumption of
soy-foods and soy-related products might have a lesser effect in MMP activities. In order to use
soy in MMPI-related cancer preventive diets, it becomes important to test its activities in cooked
seeds. This is of significant importance to understand its impact in consumer’s health. Hence, in this
work, extractions were carried out with the whole seed, including the tegument and were soaked and
cooked. To our knowledge, there are no reports comparing these types of activities in cooked and
uncooked seeds.
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3.1. Cooking Affects the Amounts of Bioactive Compounds in Soy Seeds
In the present work, we extracted the protein and non-protein fractions in soybeans and quantified
the amounts of potentially bioactive compounds before and after soaking and cooking. Previous
works have shown that the most prominent bioactive compounds in soy are saponins, polyphenols
and proteinase inhibitors. Saponins are glycosides which are usually considered undesirable in
food products because of their toxicity and hemolytic activity [52], but have been reported to have
anticancer [53–57] and anti-inflammatory [58] effects, in in vitro and in vivo assays [59,60]. Phenolic
compounds on the other hand are usually pointed out as the main responsible for the antioxidant
properties of soy [20–22,25]. Isoflavones are inarguably the most active ones, exhibiting several
biological activities against several pathologies, including as osteoporosis, cardiovascular diseases
and menopausal symptoms as well as cancer [61–63]. The anticancer effects of isoflavones have
unquestionably been most extensively studied in breast cancer [64], but less in colon cancer. As for
the protease inhibitors, which are part of the Kunitz family and Bowman–Birk family, some of
these peptides are known to have anti-inflammatory effects [65–67] and are effective in inhibiting
carcinogenesis after induction of radiation and chemical treatment [25]. However, the mechanism
responsible for this effect is still poorly studied.
The total amounts of saponins, polyphenols and proteins in each fraction (protein and non-protein)
extracted from cooked and uncooked soybean seeds are expressed in Table 1.
Table 1. Quantification of bioactive compounds saponins, polyphenols and soluble proteins in
uncooked (UC) and cooked (C) fractions of Glycine max seeds. Results represent an average of
at least three replicate experiments (n = 3) ± SD. a represents a significant difference (p < 0.05) between
cooked and uncooked seeds.
Saponins mg/g DW Phenolics mg/g DW Proteins mg/g DW
UC 3.6 ± 0.24 1.7 ± 0.16 297.4 ± 8.65
C 1.6 ± 0.24 0.7 ± 0.06 15.7 ± 4.82
% of lost 57.6 a 60.9 a 94.7 a
It is widely known that food processing improves flavor and palatability, but also increases
the bioavailability of nutrients by inactivating the antinutritional factors [52]. Many nutrients are
heat-sensitive, such as some proteins. Saponins, on the other hand, are known to be more heat
stable, but their concentration can be fairly reduced by soaking, germination and/or fermentation [62].
Previous in vitro studies suggest that cooking increases the digestibility of protein and starch reduction
of trypsin inhibitors, with no change in mean nutritional quality of these macronutrients [68,69],
although it may alter the natural antioxidant content in food [70,71].
According to Table 1, it seems clear that after soaking and cooking all metabolites were very
significantly reduced (p < 0.05) to less than 50% of their initial content. Saponins were reduced by 57.6%,
whilst polyphenols presented a 60% reduction. As expected, protein content was the most affected after
cooking, with a 94% reduction (p < 0.05). Although some of these compounds are thermoresistant as
discussed before, previous works have also determined that in soy structural phenolic compounds can
be released by thermal depolymerization during cooking [72] or by washing out during soaking [73],
which is consistent with our results. In order to understand if these cooking-induced depletion in
bioactive compounds could reduce the anticancer potential of soy we further set out to determine if
the cooking process affects or not MMPI activities in both fractions.
3.2. Proteins in Soy are Better MMP Inhibitors Than Polyphenols and Saponins
Since MMP-9 inhibitors (MMPIs) are considered anti-angiogenic agents and metastasis deterrents
for colorectal cancer, and have also been demonstrated to effectively inhibit pre-cancer states such as colitis
and other inflammatory bowel diseases [74]. In order to compare the MMP inhibitory potential of
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the protein and non-protein extracts from soybean seeds, and to select a concentration to use in the
subsequent studies, we determined the half maximal effective inhibition of MMPs (IC50) values for
soluble protein (P) and non-protein (NP) fractions. IC50 values were found to be of 91.6 ± 10 µg DW/mL
for protein fractions and 10.8 ± 0.02 mg DW/mL for phenolics and saponin extracts. These IC50
levels substantiate that both protein and non-protein fractions can indeed reduce MMP activities,
but they varied very significantly between them (p < 0.001), being 100 times lower in the protein
fractions than in the non-protein fractions. These orders of magnitude are consistent with previous
works. For instance, Lima et al. [18] found that 100 g/mL of soy albumin extract reduce 95% of MMP
activity, whereas Xu and Cheng [28] showed that up to 5 mg/mL of polyphenolic extracts from soy
are required for antioxidant and anti-proliferative activities in cancer cells. In this work, IC50 values
seem higher than previous works [18], which could be explained by the fact that we used whole
seeds with teguments. Nonetheless, the large difference between the IC50s determined for protein
fractions and the non-protein fractions clearly suggests that protein MMPIs in soy might be better
inhibitors than polyphenols and saponins. Hence, our results suggest that daily intake of soy protein
MMPIs may be of potential importance for cancer preventive diets, especially in colorectal cancer
and colon-related inflammatory diseases, where these compounds can exert their effect without being
absorbed to the bloodstream.
3.3. Cooking Affects MMP-9 Inhibitory Activities of Non-Protein Compounds, but Not of MMPI Proteins
An estimated 3.45 million new cases of cancer and 1.75 million deaths from cancer occurred in
Europe in 2012 [75], with colorectal cancer (CRC) being the second most common cause of cancer
death in the European Union [75,76] despite the intensive research made and the significant advances
in diagnosis, screening and treatment [77,78]. Several studies point to the fact that MMP activity
inhibition appears to be a promising anticancer therapy [10,79]. Within MMPs, MMP-9 is the most
studied because of their importance in cell migration, angiogenesis and metastasis formation [33,80].
Hence, we further set out to analyze the extracts’ specific activity towards MMP-9 enzymes, in their
determined IC50 concentrations, using the DQ-gelatin assay. Results are presented in Figure 1 and are
expressed as percent of MMP-9 activity in relation to controls.
Results show that indeed all uncooked extracts were able to inhibit MMP-9, as expected by the
IC50 levels, however, after soaking and cooking, only the protein extracts maintained their activities,
whilst soy NP compounds were significantly reduced (p < 0.05). These results substantiate the data in
Table 1, suggesting once again that the protein fraction in soy might hold a higher potential for MMPI
diets in more realistic scenarios.
It is known that protease inhibitor peptides are stable within reasonable limits, at elevated
temperatures, and some proteins of lower molecular weight and some leguminous species also
present thermostability, which could be the case of soybean protein fractions [71]. Through reverse
zymography, as shown in Figure 2, we could pinpoint which proteins showed a capacity for inhibition
or resistance to MMP-9, and which were resistant to cooking. In this technique, proteins are
electrophoretically separated in an acrylamid gel co-polymerized with MMP-9 and its substrate
gelatin. Hence, after incubation, the gelatin in the gel suffers MMP-9-induced proteolysis, resulting
in a clear gel. The observed remaining visible bands represent the proteins which are resistant to or
inhibit MMP-9 activity.
Figure 1 shows, as expected from Table 1, that soybean presented a high loss of protein after
cooking. In addition, reverse zymographies show the existence of some polypeptides with MMPI
activity in crude seeds, which is consistent with previous works [18]. However, after cooking, only
one polypeptide band, with approximately 25 kDa, could inhibit MMP-9. This protein band may be
one or more specific low molecular mass protein(s) with MMPI activities. In soybeans as well as other
legumes, various proteins and peptides such as lunasin, and protease inhibitors, ranging from 4 kDa
to 22 kDa have been largely studied [30,81,82], but until now they were not related to MMP inhibition.
This is the first report, to our knowledge, of a protein MMPI from soy that is also heat resistant. Since
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the DQ-gelatin as well as the zymographic analysis incubate directly the MMP-9 enzymes with the
extracts, it seems plausible to infer that these MMPIs directly bind to the enzyme, hence blocking its
activity. This is consistent with its protease inhibitory activities referred to in other studies [81,82].
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Figure 1. The eff ct of protein and non-protei fr cti s isolated from cooked or uncooked seeds of
Glycine max on the proteolytic activity of P-9. on-protein uncooked fraction (NP), non-protein
cooked fraction (NP C), protein uncooked fraction (P) and protein cooked fraction (P C). The control
does not inhibit MMP-9, resulting in 100% proteolytic activity for this protease. Protein fractions,
cooked (P C) and uncooked (P), were added at a concentration of 100 µg/mL and non-protein fractions,
cooked (NP C) and uncooked (NP) were added at a concentration of 10 mg/mL. Gelatinolytic activity
was measured by the DQ fluorogenic assay. MMP activities are expressed as relative fluorescence as
a percent of controls, and represent the averages of at least three replicate experiments (n = 3) ± SD.
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Figure 2. Cooked and uncooked protein extracts present MMPI activity. Representative images of
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3.4. Soy Polyphenols Reduce Cancer Cell Migration Even without Inhibiting MMP-9
Since the earliest work on the importance of MMPs in cancer, there has been a clear relation
between the inhibitory effect on MMP with its ability for extracellular matrix degradation and cancer
cell migration [18]. Several studies have linked the inhibition of MMPs to a corresponding inhibition
of cell invasion in standard wound healing assays [79]. In this assay, the ability of cells to invade a gap
cut in the monolayer of the cells allow an indirect measurement of their ability to metastasize and of
their MMP-9 activity [80].
Here, the studied extracts were further analyzed for their effectiveness in reducing cancer cell
migration proliferation in HT29 cells. Figure 3A,B shows cell migration patterns of HT29 cells after
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compounds presented significantly (p ≤ 0.05) lower cell migration after 48 h of incubation compared 
to the controls (Figure 3B), which was significantly higher in cooked cells (p < 0.05). Previous works 
Figure 3. HT29 cell migration after exposure to non-protein uncooked fraction (NP), non-protein
cooked fraction (NP C), protein uncooked fraction (P) and protein cooked fraction (P C), as determined
by the wound healing assays. (A) Representative images of cell migration showing the inhibitory effect
of different fractions of Glycine max seeds on HT29 cell migration. Cells were grown until reaching
80% confluence and the monolayer was scratched with a pipette tip (0 h). Cells were then expos d to
100 µg protein/mL, cooked (P C) and uncooked (P , and to 10 mg non-pro ein/ L, c oked (NP C) and
unco ked (NP) and cell migration was re orded af er 48 h; (B) Relativ migration rates. Values are the
means of at least three replicate experiments ± SD, and are expr ssed as a percent the wound closure
in relation to 0 h. * represents p < 0.05 between samples and # represents p < 0.05 when compared
to controls.
Results clearly demonstrate that the different fractions of soybeans had an inhibitory effect on cell
migration, but significant differences (p < 0.05) were observed between the protein and non-protein
fracti ns. Under their IC50 concentrations, in g neral, cells treated with non-protein compounds
presen ed significantly (p ≤ 0.05) lower cell migration after 48 h of incubation compared to the
controls (Figure 3B), which was significantly higher in cooked cells (p < 0.05). Previous works
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showed that saponins and phenolics can induce these inhibitions. Kang et al. [31] found that soybean
saponins inhibited cell migration in both HT29 cells and fibroblast cancer cells (HT1080 cells) at
a concentration of 30 to 300 µg/mL. Polyphenols present in foods have also been shown to have
antitumor activity by inhibiting cell migration, MMP secretion, cell growth and cell adhesion and
further induce apoptosis [83], which is in agreement with our results. However, in comparison, the
proteins fractions, which had induced a similar MMP-9 inhibition, did not significantly reduce cell
migration. This seems to suggest that the MMP-9 inhibition induced by this concentration of the
protein fractions is not enough to reduce cell migration. Indeed, we know from previous reports that
soy proteins can reduce cancer cell migration in concentrations of 100 µg protein/mL [18]. However,
in previous works, this concentration inhibited almost completely MMP-9 activities, which is not the
case here, since we used IC50 concentrations. It is plausible that a 50% inhibition in total gelatinases
in the extracellular media is not enough to fully reduce cell migration. Nonetheless, it is important
to highlight that the protein fraction was 100 times lower than the phenolic and saponin fraction,
hence these results do not suggest that proteins are less effective in reducing cancer cell migration.
It suggests, however, that the effect exerted by non-protein compounds in HT29 migration are not
dependent on MMP-9 inhibition as the protein effects probably are. We further set out to determine if
the inhibitions observed in cancer cell migration were related to any type of cytotoxicity or to specific
MMP-9 inhibition.
3.5. Cancer Cell Proliferation
In order to test the cytotoxic effects of the determined IC50 concentrations, we evaluated the effect
of the studied fractions on HT29 cell viability and proliferation (Figure 4).
Nutrients 2017, 9, 201  10 of 16 
 
showed t at saponins and phenol cs can induce th se inhibitions. K ng et al. [31] found that soybean 
sapo ins inhibited cell migration  in b th HT29 cells and fibroblast canc r cells (HT1080 cells) at a 











these  results do  not  suggest  that  proteins  are  less  effective  in  reducing  cancer  cell migration.  It 
suggests, however,  that  the  effect  exerted by non‐protein  compounds  in HT29 migration are not 
dependent on  MP‐9 inhibition as the protein effects probably are.  e further set out to determine 
if  the  inhibitions observed  in  cancer  cell migration were  related  to any  type of  cytotoxicity or  to 
specific MMP‐9 inhibition. 
3.5. Cancer Cell Proliferation 
In order  to  test  the cytotoxic effects of  the determined  IC50 co centrations, we evaluated  the 
effec  of the stud ed fractions on HT29 ce l vi bility and proliferat on (Figure 4). 
 
Figure  4. HT29  cell  proliferation  after  a  24  h  exposure  to  non‐protein  uncooked  fraction  (NP), 
non‐protein cooked fraction (NP C), protein uncooked fraction (P) and protein cooked fraction (P C). 
Cells were grown  for 24 h  in  the presence of 100 μg protein/mL, cooked  (P C) and uncooked  (P) 
fractions and  to 10 mg non‐protein/mL, cooked  (NP C) and uncooked  (NP)  fractions and  stained 
with MTT. Values represented are the means of at least three replicate experiments (n = 3) ± SD and 
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since  cell  viability  was  maintained,  although  after  cooking,  non‐protein  compounds  soybean 
induced  a  significant  inhibition  (p  <  0.05)  in  cell  proliferation,  suggesting  saponins  or  phenolic 
compounds  may  exert  toxic  effects  to  the  cells.  Indeed,  previous  studies  have  shown  greater 
cytotoxic effects induced by saponins and phenolics. For example, Fereidunian et al. [33] found that 
200 μg/mL of soybean BBI did decrease cell multiplication at a concentration of 400 μg/mL in HT29 
Figure 4. HT29 cell proliferation after a 2 s r t -protein unc oked fraction (NP),
no -protein cooked fraction (NP C), protein uncooke fractio ( ) and protein cooked fraction (P C).
Cells were grown for 24 h in the presence of 100 µg protein/ L, cooked (P C) and uncooked (P)
fractions and to 10 mg non-protein/mL, cooked (NP C) and uncooked (NP) fractions and stained with
MTT. Values represented are the means of at least three replicate experiments (n = 3) ± SD and are
expressed as a percentage of the control. * represents p < 0.05 between samples.
Overall, results demonstrate that most of the extracts did not show cytotoxicity to the cells, since
cell viability was maintained, although after cooking, non-protein compounds soybean induced a
significant inhibition (p < 0.05) in cell proliferation, suggesting saponins or phenolic compounds may
exert toxic effects to the cells. Indeed, previous studies have shown greater cytotoxic effects induced
by saponins and phenolics. For example, F reid nian et al. [33] found th 200 µg/mL of soybean BBI
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did decrease cell multiplication at a concentration of 400 µg/mL in HT29 cells. However, these works
involved specific isolated molecules, and in higher concentrations. The fact that the extracts tested here
induced greater effect on the cell migration, and not on cell multiplication may also be associated to
their mechanism of inhibition. One of the factors most associated with the reduction of cell migration
rate is the activity of MMP-2 and MMP-9. Thus, in this work, the gelatinolytic activity of the HT29
cells extracellular medium was further analyzed after exposure to different NP and P fractions.
3.6. Soy Extracts Inhibit MMP-9 in HT-29 Extracellular Media, but Not MMP-2
Under normal conditions, cancer cells secrete active MMP-2 and MMP-9 into the extracellular
medium and upon degradation of the surrounding environment, they are able to proceed with cell
migration [3,80], and consequently with the formation of metastases. The specificity of MMP inhibition
may be of significant importance in this matter, because it may maintain low secondary effects and
also induce higher efficacy in prevention or treatment. The inhibition of MMP-2 or MMP-9 in the HT29
cells exposed to the different soy extracts was analyzed through zymographic analysis as well as the
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Figure 5. (A) Representative image of the zymographic profiles of MMP-9 and MMP-2 activities in
presence to different co ked and unco ked fractions isolated from soy se ds. MMP-9 and MMP-2
proteolytic activities were detected in HT29 extracel ular media after a 48 h exposure to 10 µg
protein/ cooke (P C) and uncooked (P) fractions and 10 mg non-protein/ L cooked (NP C) and
unco ked (NP) fractions isolated from Glycine max se ds. HT29 extracel ular media were loaded in
12.5% (w/v acryla ide) polyacryla ide gels co-polymerized with 1% (w/v) gelatin; (B) Proteolytic
activity of gelatinases present in the HT29 extracel ular media after a 48 h exposure to 10 µg
protein/ e (P) fractions and to 10 mg non-protein/mL cooked (NP
C) and uncooked (NP) fractions isolated from Glycine ax see s, ifi t e fluorogenic
method. lt relati fluoresce c as a percent of controls and represent an
average of at least thre replicate xperiments (n = 3) ± S . * represents p < 0.05 between samples and
# represents p < 0.05 compared to controls.
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Both gelatinolytic activities show a significant decrease (p ≤ 0.05) in the presence all the studied
fractions, which is consistent to the previous results and to the cell migration inhibition. However,
although non-protein fractions were more effective in reducing cell migration, soluble proteins (both
uncooked and cooked) showed greater ability to inhibit gelatinolytic activity when compared to the
non-protein compounds (p ≤ 0.05) inhibiting more than 80% of MMP activity. In fact, non-protein
extracts were much less efficient in inhibiting both gelatinases. These results corroborate that soy
proteins are indeed more efficient in inhibiting MMPs than non-protein compounds. On the other
hand, the fact that the non-protein compounds did not inhibit MMPs but reduced multiplication
and invasion substantiates that they may be associated with another anticancer mechanism besides
gelatinase inhibition, such as in the decrease of reactive species of oxygen [83], or others.
Moreover, zymographic results also show that in general, soy protein extracts were much more
effective in inhibiting pro-MMP-9 (92 kDa) and active MMP-9 (83 kDa), than the pro-MMP-2 and
MMP-2. It is known that MMP inhibitors may have an action at different molecular levels: (i) inhibition
of transcription; (ii) inhibition of post-transcription; (iii) inhibition of translation; (iv) post-translational
degradation; and (v) inhibition of secretion or activity [33]. In this case, inhibition of active MMP-9
may have been achieved either by a direct inhibition of MMP-9 expression or activity, since there
was also a decrease in pro-MMP-9. Either way, because most of the problems involved with MMP
inhibitors are related to their lack of specificity [11,15], the finding of specific MMP-9 inhibitors in
soy can be of significant importance for our understanding of the anticancer and anti-inflammatory
mechanisms in this legume species.
4. Conclusions
Overall, our work shows that protein fractions in soybeans might have a higher role in soy-related
cancer prevention and reduction than previously expected. First, we showed for the first time
that the protein fractions of soy seeds are more effective and selective MMP-9 inhibitors than the
non-proteins compounds. Furthermore, they remain active after cooking. Finally, they are more specific
inhibitors of MMP-9. The discovery of heat-resistant specific MMPI proteins in soy can be of significant
importance for cancer preventive diets, particularly considering the increasing use of soy proteins in
food products. However, mostly, with all the controversy around the consumption of soy isoflavones
in diets, our results open doors to developing novel strategies using soy in cancer preventive diets
without consumer concerns regarding potential health risks of polyphenols and saponins.
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